Phase 2 Craniopharyngioma Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
CraniopharyngiomaCraniopharyngioma, ChildRecurrent Craniopharyngioma
Sabine Mueller, MD, PhD57 enrolled20 locationsNCT05465174
Recruiting
Phase 2
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Adamantinomatous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma
Nationwide Children's Hospital30 enrolled14 locationsNCT05233397
Recruiting
Phase 2
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Adamantinous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma
Nationwide Children's Hospital38 enrolled10 locationsNCT05286788
Recruiting
Phase 1Phase 2
Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma
Craniopharyngiomas
Nanfang Hospital, Southern Medical University57 enrolled1 locationNCT06970145
Recruiting
Phase 2
Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
CraniopharyngiomaHypothalamic ObesityHypothalamic Tumor
Seattle Children's Hospital24 enrolled2 locationsNCT06299891
Recruiting
Phase 2
Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma
Craniopharyngioma
Eva Marie Erfurth, MD, PhD25 enrolled1 locationNCT05525273